# Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma

> **NCT03973008** · PHASE3 · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 408 (estimated)

## Conditions studied

- Gastric Adenocarcinoma

## Interventions

- **RADIATION:** Adjuvant Chemoradiotherapy
- **DRUG:** Adjuvant Chemotherapy

## Key facts

- **NCT ID:** NCT03973008
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-11
- **Primary completion:** 2024-02-29
- **Final completion:** 2025-05-31
- **Target enrollment:** 408 (ESTIMATED)
- **Last updated:** 2019-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03973008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03973008, "Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03973008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
